These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Räisänen-Sokolowski A; Glysing-Jensen T; Koglin J; Russell ME Am J Pathol; 1998 Feb; 152(2):359-65. PubMed ID: 9466561 [TBL] [Abstract][Full Text] [Related]
30. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684 [TBL] [Abstract][Full Text] [Related]
31. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Miura M; El-Sawy T; Fairchild RL Am J Pathol; 2003 Feb; 162(2):509-19. PubMed ID: 12547709 [TBL] [Abstract][Full Text] [Related]
32. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458 [TBL] [Abstract][Full Text] [Related]
33. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts. Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726 [TBL] [Abstract][Full Text] [Related]
34. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. Tran EH; Prince EN; Owens T J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118 [TBL] [Abstract][Full Text] [Related]
35. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity. McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996 [TBL] [Abstract][Full Text] [Related]
36. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900 [TBL] [Abstract][Full Text] [Related]